In the past week, BIAF stock has gone up by 2.77%, with a monthly decline of -54.92% and a quarterly plunge of -73.66%. The volatility ratio for the week is 25.98%, and the volatility levels for the last 30 days are 18.31% for BioAffinity Technologies Inc The simple moving average for the last 20 days is -40.31% for BIAF stock, with a simple moving average of -80.20% for the last 200 days.
Is It Worth Investing in BioAffinity Technologies Inc (NASDAQ: BIAF) Right Now?
BIAF has 36-month beta value of 2.40. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for BIAF is 13.51M, and currently, short sellers hold a 2.14% ratio of that float. The average trading volume of BIAF on May 19, 2025 was 9.78M shares.
BIAF) stock’s latest price update
The stock of BioAffinity Technologies Inc (NASDAQ: BIAF) has increased by 2.97 when compared to last closing price of 0.21. Despite this, the company has experienced a 2.77% gain in its stock price over the last five trading sessions. businesswire.com reported 2025-05-15 that SAN ANTONIO–(BUSINESS WIRE)– #BIAF–bioAffinity Technologies reports first-quarter 2025 results.
BIAF Trading at -48.98% from the 50-Day Moving Average
After a stumble in the market that brought BIAF to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.92% of loss for the given period.
Volatility was left at 18.31%, however, over the last 30 days, the volatility rate increased by 25.98%, as shares sank -58.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -44.29% lower at present.
During the last 5 trading sessions, BIAF rose by +2.77%, which changed the moving average for the period of 200-days by -91.14% in comparison to the 20-day moving average, which settled at $0.3547. In addition, BioAffinity Technologies Inc saw -76.74% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for BIAF
Current profitability levels for the company are sitting at:
- -1.09 for the present operating margin
- 0.29 for the gross margin
The net margin for BioAffinity Technologies Inc stands at -1.11. The total capital return value is set at -4.52. Equity return is now at value -290.85, with -143.25 for asset returns.
Based on BioAffinity Technologies Inc (BIAF), the company’s capital structure generated 0.48 points at debt to capital in total, while cash flow to debt ratio is standing at -4.93. The debt to equity ratio resting at 0.92. The interest coverage ratio of the stock is -180.3.
Currently, EBITDA for the company is -8.33 million with net debt to EBITDA at -0.1. When we switch over and look at the enterprise to sales, we see a ratio of 0.76. The receivables turnover for the company is 9.14for trailing twelve months and the total asset turnover is 1.59. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.55.
Conclusion
To put it simply, BioAffinity Technologies Inc (BIAF) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
